A comparative review study of Sneha Kalpana (Paka) vis-a-vis liposome

Ayurvedic dosage forms are very exclusive in its pharmaceutics and therapeutics. Sneha Kalpana is a group of products of medicated taila and ghee, these drugs are treating very wide range of diseases among patients of all age groups. Liposomal system of drug delivery is a new invention in conventional system of medicine. This system is also covering a high degree of objective of therapeutics at different targets successfully. Probably, here is very distinctive similarity between these two on account of their aqueous and oleaginous origin. Most likely, these are two faces of same coin. A brief survey of literature is done here to explore possibilities of further investigation in benefit of mankind by applying wisdom of both fields together. In fact, this is a review paper based on certain hypothesis which may be established or rejected factually by further researches.

[1]  B. Ravishankar,et al.  A comparative pharmacological investigation of three samples of 'Guduchi ghrita' for adaptogenic activity against forced swimming induced gastric ulceration and hematological changes in albino rats , 2010, International journal of Ayurveda research.

[2]  P. Lahorkar,et al.  A Comparative Evaluation of Medicated Oils Prepared Using Ayurvedic and Modified Processes , 2009, Indian journal of pharmaceutical sciences.

[3]  A. Sharma,et al.  Development of Solid Lipid Nanoparticles of Lamivudine for Brain Targeting , 2009 .

[4]  M. Radomski,et al.  Nanoparticles: pharmacological and toxicological significance , 2007, British journal of pharmacology.

[5]  G. Gregoriadis.  Interactions of liposomes with the biological milieu , 2007 .

[6]  O. Katare,et al.  Liposomal drug delivery systems--clinical applications. , 2005, Acta pharmaceutica.

[7]  M. Hashida,et al.  An application of water-in-oil and gelatin-microsphere-in-oil emulsions to specific delivery of anticancer agent into stomach lymphatics , 1977, Journal of Pharmacokinetics and Biopharmaceutics.

[8]  S. G. Wadodkar,et al.  Evaluation of CNS activity of Bramhi Ghrita , 2005 .

[9]  M. R. Mozafari,et al.  Liposomes: an overview of manufacturing techniques. , 2005, Cellular & molecular biology letters.

[10]  A. Ray,et al.  STANDARDISATION OF KSHEERABALA TAILA , 1996, Ancient science of life.

[11]  H. Noteborn,et al.  Drug delivery systems. , 1989, Current opinion in oncology.

[12]  R. W. Baldwin,et al.  Adsorption of monoclonal antibodies to polyhexylcyanoacrylate nanoparticles and subsequent immunospecific binding to tumour cells in vitro , 1983 .

[13]  Patrick Couvreur,et al.  Pharmacokinetics and Distribution of a Biodegradable Drug-carrier , 1983 .

[14]  C. Pi.  Toxicity of some charged lipids used in liposome preparations. , 1983 .

[15]  P I Campbell,et al.  Toxicity of some charged lipids used in liposome preparations. , 1983, Cytobios.

[16]  Y. Mizushima,et al.  Use of a lipid emulsion as a novel carrier for corticosteroids , 1982, The Journal of pharmacy and pharmacology.

[17]  N. Rooijen,et al.  Liposomes in immunology: multilamellar phosphatidylcholine liposomes as a simple, biodegradable and harmless adjuvant without any immunogenic activity of its own. , 1980 .

[18]  N. Van Rooijen,et al.  Liposomes in immunology: multilamellar phosphatidylcholine liposomes as a simple, biodegradable and harmless adjuvant without any immunogenic activity of its own. , 1980, Immunological communications.

[19]  G. Gregoriadis.  Targeting of drugs , 1977, Nature.